• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2025 RESULTS

    10/30/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials
    Get the next $KWR alert in real time by email
    • Q3'25 net sales of $493.8 million, an increase of 7% Y/Y
    • Organic sales volumes increased 3% Y/Y driven by new business wins of approximately 5%
    • Q3'25 net income of $30.5 million and earnings per diluted share of $1.75
    • Non-GAAP net income of $36.3 million and non-GAAP earnings per diluted share of $2.08, an increase of 10% Y/Y
    • Delivered adjusted EBITDA of $82.9 million, a 5% increase Y/Y, and adjusted EBITDA margins of 16.8%
    • Generated $51.4 million of operating cash flow in Q3'25; Reduced net leverage ratio to 2.4x

    CONSHOHOCKEN, Pa., Oct. 30, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial process fluids, announced its third quarter 2025 results today.



    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,

    ($ in thousands, except per share data)

    2025

    2024

    2025

    2024

    Net sales

    $            493,842

    $            462,274

    $      1,420,156

    $      1,395,600

    Net income (loss) attributable to Quaker Chemical Corporation

    30,469

    32,346

    (23,189)

    102,458

    Net income (loss) attributable to Quaker Chemical Corporation common shareholders – diluted

     

    1.75

     

    1.81

     

    (1.32)

     

    5.70

    Non-GAAP net income *

    36,270

    33,981

    94,298

    109,886

    Non-GAAP Earnings per diluted share *

    2.08

    1.89

    5.37

    6.11

    Adjusted EBITDA *

    82,851

    78,562

    227,377

    246,135





    *

    Refer to the Non-GAAP Measures and Reconciliations section below for additional information

    Third Quarter 2025 Consolidated Results

    Net sales in the third quarter of 2025 were $493.8 million, an increase of 7% compared to $462.3 million in the third quarter of 2024. This increase was primarily driven by an increase in organic sales volumes of 3%, a contribution from acquisitions of 5% and a favorable impact from foreign currency translation of 1%, partially offset by a decline in selling price and product mix of 2%. Organic sales volumes increased in all segments compared to the prior year, led by an 8% increase in the Asia/Pacific segment. This improvement in organic sales volumes was primarily driven by new business wins of approximately 5% globally, more than offsetting a continuation of soft end market conditions, particularly in the Americas and EMEA segments. The decrease in selling price and product mix was primarily attributable to the impact of the mix of products, services and geographies and the impact of our index-based customer contracts. Organic sales volumes increased 1% compared to the second quarter of 2025.

    The Company reported net income in the third quarter of 2025 of $30.5 million, or $1.75 per diluted share, compared to $32.3 million, or $1.81 per diluted share, in the third quarter of 2024. Excluding non-recurring and non-core items in each period, the Company's non-GAAP net income and non-GAAP earnings per diluted share were $36.3 million and $2.08 respectively in the third quarter of  2025 compared to $34.0 million and $1.89 respectively in the third quarter of 2024. The Company generated adjusted EBITDA of $82.9 million in the third quarter of 2025, an increase of approximately 5% compared to $78.6 million in the third quarter of 2024, driven by the increase in net sales and consistent operating margins. See the Non-GAAP Measures and Reconciliations section below for additional information.

    Joe Berquist, Chief Executive Officer and President, commented, "Third quarter results were strong, resulting from the team's disciplined execution of our strategy. We achieved a 7% increase in sales on 3% organic volume growth, and a 5% improvement in adjusted EBITDA in the quarter, despite a softer than anticipated end market environment. Our performance was driven by new business wins of approximately 5% globally and amplified by continued momentum in Asia/Pacific. We are advancing our strategic initiatives, leveraging our scale and managing costs to enhance our global competitiveness and improve margins. Solid cash generation enabled us to further strengthen our balance sheet and return cash to shareholders through dividends and share repurchases.

    "We anticipate the current soft environment will persist at least through year end, with normal seasonality expected. The resilience of our business is evident. We are confident in our ability to convert our sales pipeline and have line of sight to execute our ongoing cost and productivity initiatives. We expect to deliver year-over-year revenue and earnings growth in the fourth quarter, and are building momentum on our enterprise strategy to sustain above market growth in 2026 and beyond."

    Third Quarter 2025 Segment Results

    The Company's third quarter and nine months of 2025 operating performance for each of its three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific, is further described below.



    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,



    2025

    2024

    2025

    2024

    Net Sales *









    Americas

    $          222,787

    $          220,275

    $          657,560

    $          673,546

    EMEA

    143,900

    134,135

    413,101

    410,558

    Asia/Pacific

    127,155

    107,864

    349,495

    311,496

    Total net sales

    $          493,842

    $          462,274

    $      1,420,156

    $      1,395,600

    Segment operating earnings *









    Americas

    $            58,913

    $            62,121

    $          176,351

    $          193,027

    EMEA

    26,479

    24,644

    74,867

    80,867

    Asia/Pacific

    35,569

    30,656

    90,214

    92,033

    Total segment operating earnings

    $          120,961

    $          117,421

    $          341,432

    $          365,927





    *

    Refer to the Segment Measures and Reconciliations section below for additional information

    The following table summarizes the sales variances by reportable segment and consolidated operations in the third quarter of 2025 compared to the third quarter of 2024:



    Sales 

    volumes

    Selling price &

    product mix

    Foreign

    currency

    Acquisition &

    other

    Total

    Americas

    — %

    (2) %

    1 %

    2 %

    1 %

    EMEA

    1 %

    1 %

    3 %

    2 %

    7 %

    Asia/Pacific

    8 %

    (5) %

    1 %

    14 %

    18 %

    Consolidated

    3 %

    (2) %

    1 %

    5 %

    7 %

    Net sales in the Asia/Pacific segment increased 18% in the third quarter of 2025 compared to the same period in 2024, as an increase in organic sales volumes, a further contribution in sales from acquisitions, primarily Dipsol, and a favorable impact of foreign currency translation, was partially offset by a decrease in selling price and product and geographic mix. Net sales in the EMEA segment increased 7% in the third quarter of 2025 compared to the same period in 2024, due to an increase in organic sales volumes, a further increase in sales from acquisitions, an increase in selling price and product mix, and a favorable impact of foreign currency translation. Net sales in the Americas segment increased 1% in the third quarter of 2025 compared to the same period in 2024, due to a contribution in sales from acquisitions and a favorable impact from foreign currency translation, partially offset by a decline in selling price and product mix. Organic sales volumes in the Americas were consistent with the prior year period.

    New business wins were strong across all segments in the third quarter of 2025 despite softer underlying end market activity compared to prior year levels. The decline in selling price and product mix in the third quarter of 2025 compared to the same period in 2024 reflects changes in the mix of products, services and geographies, and the impact of our index-based customer contracts.

    Consolidated net sales increased approximately 2% compared to the second quarter of 2025, driven by an increase in organic sales volumes and a favorable impact from foreign currency translation. Selling price and product mix was consistent with the prior quarter. Net sales increased in all segments compared to the second quarter of 2025 driven by new business wins, despite a continuation of soft underlying end market activity. Organic sales volumes increased in the Asia/Pacific and Americas segments but declined in EMEA. Foreign currency translation was favorable to sales across all segments in the third quarter of 2025 compared to the second quarter of 2025.

    Segment operating earnings increased in the EMEA and Asia/Pacific segments in the third quarter of 2025 compared to the prior year, primarily due to the improvement in net sales. Segment operating earnings decreased in the Americas segment in the third quarter of 2025 compared to the prior year as an increase in net sales was offset by a modest decline in segment operating margins. Segment operating earnings increased in the Asia/Pacific and EMEA segments in the third quarter of 2025 compared to the second quarter of 2025, primarily driven by an increase in net sales, and declined slightly in the Americas segment.

    Cash Flow and Liquidity Highlights

    Net cash provided by operating activities was $89.9 million for the nine months ended September 30, 2025, compared to $141.5 million for the same period in 2024. The Company's operating cash flow primarily reflects a lower operating performance, higher cash outflows from restructuring activities, and higher cash outflows for working capital activities, primarily due to lower inflows from the timing of collection of accounts receivable and higher outflows for the purchases of inventories.

    As of September 30, 2025, the Company's total gross debt was $875.2 million and its cash and cash equivalents was $172.0 million, which resulted in net debt of approximately $703.2 million. The Company's net debt divided by its trailing twelve months adjusted EBITDA was approximately 2.4x. The increase in the company's leverage ratio compared to the prior year primarily reflects the Company's acquisition of Dipsol, which was completed in April 2025, and was funded with borrowings under the Company's existing credit facility. In the third quarter of 2025, the Company reduced outstanding gross debt by approximately $61.5 million compared to the second quarter of 2025, and repurchased 29,791 shares for $3.8 million.

    Non-GAAP Measures and Reconciliations

    The information in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, facilitate a comparison among fiscal periods, and exclude items that management believes are not indicative of future operating performance or considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income, and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable GAAP measures, may not be comparable to similarly named measures reported by other companies.

    The Company presents EBITDA, which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. In addition, the Company presents non-GAAP operating income, which is calculated as operating income plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. Additionally, the Company presents non-GAAP gross profit, which is calculated as gross profit plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. In addition, the Company presents non-GAAP Adjusted EBITDA margin, non-GAAP operating margin, and non-GAAP gross margin, which are calculated as the percentage of adjusted EBITDA, non-GAAP operating income, and non-GAAP gross profit to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.

    Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the performance of the Company on a consistent basis.

    As it relates to future projections for the Company as well as other forward-looking information contained in this press release, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to determine with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort. These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income. These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period.

    The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended September 30, 2025 adjusted EBITDA of $292.2 million, which consists of (i) the nine months ended September 30, 2025 adjusted EBITDA of $227.4 million, as presented in the non-GAAP reconciliations below, and (ii) the twelve months ended December 31, 2024 adjusted EBITDA of $310.9 million, as presented in the non-GAAP reconciliations included in the Company's fourth quarter and full year 2024 results press release dated February 24, 2025, less (iii) the nine months ended September 30, 2024 adjusted EBITDA of $246.1 million, as presented in the non-GAAP reconciliations below.

    Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):

    Non-GAAP Gross Profit and Margin Reconciliations

    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,



    2025

    2024

    2025

    2024

    Gross profit

    $      180,865

    $      172,549

    $      513,848

    $      529,830

    Acquisition-related step-up inventory amortization

    —

    —

    6,022

    —

    Loss (gain) on inventory and other adjustments

    671

    —

    (2,933)

    —

    Non-GAAP gross profit

    $      181,536

    $      172,549

    $      516,937

    $      529,830

    Non-GAAP profit margin (%)

    36.8 %

    37.3 %

    36.4 %

    38.0 %

    Non-GAAP Operating Income and Margin Reconciliations

    Three Months Ended 

    September 30,

    Nine Months Ended 

    September 30,



    2025

    2024

    2025

    2024

    Operating income

    $        46,641

    $        51,718

    $         21,755

    $       165,693

    Acquisition-related step-up inventory amortization

    —

    —

    6,022

    —

    Restructuring and related charges, net

    7,745

    2,610

    31,128

    4,787

    Acquisition-related expenses

    642

    381

    4,775

    898

    Loss (gain) on inventory and other adjustments

    671

    —

    (3,256)

    —

    Customer insolvency costs

    —

    —

    —

    1,522

    Impairment charges

    —

    —

    88,840

    —

    Acquisition-related depreciation and amortization

    1,656

    —

    3,337

    —

    Other charges (credits)

    530

    (519)

    1,695

    347

    Non-GAAP operating income

    $        57,885

    $        54,190

    $       154,296

    $       173,247

    Non-GAAP operating margin (%)

    11.7 %

    11.7 %

    10.9 %

    12.4 %

     

    EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin

    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,

    and Non-GAAP Net Income Reconciliations

    2025

    2024

    2025

    2024

    Net income (loss) attributable to Quaker Chemical Corporation

    $        30,469

    $        32,346

    $        (23,189)

    $       102,458

    Depreciation and amortization (a)

    24,436

    21,423

    69,187

    63,907

    Interest expense

    10,941

    10,347

    33,265

    31,925

    Taxes on income before equity in net income of associated companies (b)

     

    9,266

     

    12,167

     

    22,280

     

    40,453

    EBITDA

    75,112

    76,283

    101,543

    238,743

    Equity income in a captive insurance company

    (1,691)

    (285)

    (4,437)

    (1,266)

    Acquisition-related step-up inventory amortization

    —

    —

    6,022

    —

    Restructuring and related charges, net

    7,745

    2,610

    31,128

    4,787

    Acquisition-related expenses

    642

    381

    4,775

    898

    Loss (gain) on inventory and other adjustments

    671

    —

    (3,256)

    —

    Pension and postretirement benefit costs, non-service

    components

    469

    469

    1,351

    1,398

    Customer insolvency costs

    —

    —

    —

    1,522

    Impairment charges

    —

    —

    88,840

    —

    Product liability claim costs, net

    —

    —

    —

    896

    Business interruption insurance proceeds

    —

    (1,000)

    —

    (1,000)

    Currency conversion impacts of hyper-inflationary economies

    886

    624

    2,073

    333

    Loss on acquisition-related hedges

    —

    —

    1,351

    —

    Gain on sale of assets

    —

    —

    (2,534)

    —

    Multiemployer plan withdrawal charge

    923

    —

    923

    —

    Brazilian non-income tax credits

    (1,762)

    —

    (1,762)

    —

    Other charges (credits)

    (144)

    (520)

    1,360

    (176)

    Adjusted EBITDA

    $        82,851

    $        78,562

    $       227,377

    $       246,135

    Adjusted EBITDA margin (%)

    16.8 %

    17.0 %

    16.0 %

    17.6 %











    Adjusted EBITDA

    $        82,851

    $        78,562

    $         227,377

    $         246,135

    Less: Depreciation and amortization (a)

    24,436

    21,423

    69,187

    63,907

    Less: Interest expense

    10,941

    10,347

    33,265

    31,925

    Less: Taxes on income before equity in net income of associated companies - adjusted (b)

     

    12,860

     

    12,811

     

    33,964

     

    40,417

    Plus: Acquisition-related depreciation and amortization

    1,656

    —

    3,337

    —

    Non-GAAP net income

    $        36,270

    $        33,981

    $         94,298

    $         109,886

     



    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,

    Non-GAAP Earnings per Diluted Share Reconciliations

    2025

    2024

    2025

    2024

    GAAP earnings (loss) per diluted share attributable to Quaker

    Chemical Corporation common shareholders

    $                1.75

    $                1.81

     

    $               (1.32)

     

    $                 5.70

    Equity income in a captive insurance company

    (0.10)

    (0.02)

    (0.25)

    (0.07)

    Acquisition-related step-up inventory amortization

    —

    —

    0.25

    —

    Restructuring and related charges, net

    0.30

    0.11

    1.31

    0.20

    Acquisition-related expenses

    0.02

    0.02

    0.21

    0.04

    Loss (gain) on inventory and other adjustments

    0.02

    —

    (0.14)

    —

    Pension and postretirement benefit costs, non-service

    components

    0.02

    0.02

    0.06

    0.06

    Customer insolvency costs

    —

    —

    —

    0.06

    Impairment charges

    —

    —

    4.91

    —

    Product liability claim costs, net

    —

    —

    —

    0.04

    Business interruption insurance proceeds

    —

    (0.04)

    —

    (0.04)

    Currency conversion impacts of hyper-inflationary economies

    0.05

    0.04

    0.12

    0.02

    Loss on acquisition-related hedges

    —

    —

    0.06

    —

    Gain on sale of assets

    —

    —

    (0.11)

    —

    Multiemployer plan withdrawal charge

    0.04

    —

    0.04

    —

    Brazilian non-income tax credits

    (0.08)

    —

    (0.08)

    —

    Other charges (credits)

    0.02

    (0.03)

    0.07

    (0.01)

    Discrete tax items

    (0.02)

    (0.02)

    0.11

    0.11

    Acquisition-related depreciation and amortization

    0.06

    —

    0.13

    —

    Non-GAAP earnings per diluted share

    $                2.08

    $                1.89

    $                 5.37

    $                 6.11





    a.

    Depreciation and amortization for the three and nine months ended September 30, 2025 and 2024 each includes approximately $0.2 million and $0.7 million, respectively, of amortization expense recorded within equity in net income of associated companies in the Company's Condensed Consolidated Statements of Operations. This is attributable to the amortization of the fair value purchase accounting step-up in connection with the acquisition of the Company's 50% equity interest in Korea Houghton Corporation.





    b.

    Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits for the three and nine months ended September 30, 2025 and 2024.

    Segment Measures and Reconciliations

    Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related product costs and other operating expenses. Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and restructuring charges, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include Interest expense and Other (expense) income, net.

    The following table presents information about the performance of the Company's reportable segments (dollars in thousands):



    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,



    2025

    2024

    2025

    2024

    Net Sales









    Americas

    $          222,787

    $          220,275

    $          657,560

    $          673,546

    EMEA

    143,900

    134,135

    413,101

    410,558

    Asia/Pacific

    127,155

    107,864

    349,495

    311,496

    Total net sales

    $          493,842

    $          462,274

    $      1,420,156

    $      1,395,600

    Segment operating earnings









    Americas

    $            58,913

    $            62,121

    $          176,351

    $          193,027

    EMEA

    26,479

    24,644

    74,867

    80,867

    Asia/Pacific

    35,569

    30,656

    90,214

    92,033

    Total segment operating earnings

    120,961

    117,421

    341,432

    365,927

    Restructuring and related charges, net

    (7,745)

    (2,610)

    (31,128)

    (4,787)

    Impairment charges

    —

    —

    (88,840)

    —

    Non-operating and administrative expenses

    (49,560)

    (47,778)

    (151,137)

    (149,538)

    Depreciation of corporate assets and amortization

    (17,015)

    (15,315)

    (48,572)

    (45,909)

    Operating income

    46,641

    51,718

    21,755

    165,693

    Other (expense) income, net

    (270)

    783

    (1,632)

    2,285

    Interest expense

    (10,941)

    (10,347)

    (33,265)

    (31,925)

    Income (loss) before taxes and equity in net income of associated companies

     

    $            35,430

     

    $            42,154

     

    $          (13,142)

     

    $          136,053

    Forward-Looking Statements

    This press release contains "forward-looking statements" that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on assumptions, projections and expectations about future events that we believe are reasonable based on currently available information, including statements regarding the potential effects of economic downturns; tariffs, including the uncertainty surrounding changes in tariffs; inflation and global supply chain constraints on the Company's business, results of operations, and financial condition; our expectation that we will maintain sufficient liquidity and remain in compliance with the terms of the Company's credit facility; expectations about future demand and raw material costs; and statements regarding the impact of increased raw material costs and pricing initiatives. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, which may differ materially from our actual results, including but not limited to the potential benefits or uncertainties of acquisitions and divestitures, the impacts on our business as a result of global supply chain constraints, and our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "outlook, "target", "possible", "potential", "plan" or similar expressions. Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. A major risk is that demand for the Company's products and services is largely derived from the demand for our customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production slowdowns and shutdowns. Other major risks and uncertainties include, but are not limited to inflationary pressures, including increases in raw material costs; supply chain constraints and the impacts of economic downturns; customer financial instability; high interest rates and their impact on our and our customers' business operations; the impacts from acts of war, terrorism and military conflicts, including those in Ukraine and the Middle East as well as economic, political and governmental actions taken by various governments and governmental organizations in response; economic and political disruptions particularly in light of numerous elections globally and the possibility of regime changes; the possibility of economic recession; legislative and regulatory developments including changes to existing laws and regulations, or the way they are interpreted, applied or enforced; tariffs, retaliatory tariffs, "trade wars" and trade restrictions, and the economic and other sanctions imposed by other nations on Russia and Belarus and/or other government organizations; suspensions of activities in Russia by many multinational companies; foreign currency fluctuations; significant changes in applicable tax rates and regulations and the potential impacts therefrom, including those arising from H.R.1, commonly known as the "One Big Beautiful Bill Act"; future terrorist attacks and other acts of violence; the impacts of consolidation in our industry, including loss or consolidation of a major customer; the effects of climate change, fires or other natural disasters; the potential occurrence of cyber-security breaches, cyber-security attacks and other technology outages and security incidents; and U.S. political conditions and legislative and regulatory activity (or inactivity), including adoption of (or failure to adopt) new laws, regulations and executive orders, changes in existing laws, regulations and executive orders or the way they are interpreted or applied, and adoption of laws, regulations or executive orders that conflict among jurisdictions in which we operate. Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automotive, aerospace, industrial equipment, aluminum and durable goods industries. Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. All forward-looking statements included in this press release, including expectations about business conditions during 2025 and future periods, are based upon information available to the Company as of the date of this press release, which may change. Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, and in subsequent reports filed from time to time with the Securities and Exchange Commission. We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

    Conference Call

    As previously announced, the Company's investor conference call to discuss its third quarter of 2025 performance is scheduled for Friday, October 31, 2025 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756.

    About Quaker Houghton

    Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,400 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more.

    Quaker Chemical Corporation

    Condensed Consolidated Statements of Operations

    (Unaudited; Dollars in thousands, except per share data)









    Three Months Ended

    September 30,

    Nine Months Ended

    September 30,



    2025

    2024

    2025

    2024

    Net sales

    $          493,842

    $          462,274

    $      1,420,156

    $      1,395,600

    Cost of goods sold

    312,977

    289,725

    906,308

    865,770

    Gross profit

    180,865

    172,549

    513,848

    529,830

    Selling, general and administrative expenses

    126,479

    118,221

    372,125

    359,350

    Impairment charges

    —

    —

    88,840

    —

    Restructuring and related charges, net

    7,745

    2,610

    31,128

    4,787

    Operating income

    46,641

    51,718

    21,755

    165,693

    Other (expense) income, net

    (270)

    783

    (1,632)

    2,285

    Interest expense

    (10,941)

    (10,347)

    (33,265)

    (31,925)

    Income (loss) before taxes and equity in net income of associated companies

     

    35,430

     

    42,154

     

    (13,142)

     

    136,053

    Taxes on income before equity in net income of associated companies

     

    9,266

     

    12,167

     

    22,280

     

    40,453

    Income (loss) before equity in net income of associated companies

     

    26,164

     

    29,987

     

    (35,422)

     

    95,600

    Equity in net income of associated companies

    4,322

    2,385

    12,262

    6,940

    Net income (loss)

    30,486

    32,372

    (23,160)

    102,540

    Less: Net income attributable to noncontrolling interest

    17

    26

    29

    82

    Net income (loss) attributable to Quaker Chemical Corporation

    $            30,469

    $            32,346

    $          (23,189)

    $          102,458

    Per share data:









    Net income (loss) attributable to Quaker Chemical Corporation

    common shareholders – basic

     

    $                1.75

     

    $                1.81

     

    $               (1.32)

     

    $                5.71

    Net income (loss) attributable to Quaker Chemical Corporation

    common shareholders – diluted

     

    $                1.75

     

    $                1.81

     

    $               (1.32)

     

    $                5.70

    Basic weighted average common shares outstanding

    17,363,947

    17,837,858

    17,524,377

    17,889,168

    Diluted weighted average common shares outstanding

    17,421,090

    17,864,335

    17,545,666

    17,909,967

     

    Quaker Chemical Corporation

    Condensed Consolidated Balance Sheets

    (Unaudited; Dollars in thousands, except par value)



    September 30,

    2025

    December 31,

    2024

    ASSETS





    Current assets





    Cash and cash equivalents

    $           172,038

    $          188,880

    Accounts receivable, net

    436,216

    400,126

    Inventories

    268,608

    227,472

    Prepaid expenses and other current assets

    69,123

    59,939

    Total current assets

    945,985

    876,417







    Property, plant and equipment, net

    295,784

    229,532

    Right-of-use lease assets

    38,454

    34,120

    Goodwill

    501,767

    518,894

    Other intangible assets, net

    890,645

    827,098

    Investments in associated companies

    106,783

    98,012

    Deferred tax assets

    10,050

    9,216

    Other non-current assets

    27,329

    17,360

    Total assets

    $       2,816,797

    $      2,610,649







    LIABILITIES AND EQUITY





    Current liabilities





    Short-term borrowings and current portion of long-term debt

    $             35,949

    $            37,554

    Accounts payable

    205,541

    198,137

    Dividends payable

    8,825

    8,572

    Accrued compensation

    42,095

    50,212

    Accrued restructuring

    4,800

    2,297

    Accrued pension and postretirement benefits

    2,259

    2,328

    Other accrued liabilities

    83,930

    80,668

    Total current liabilities

    383,399

    379,768







    Long-term debt

    838,522

    669,614

    Long-term lease liabilities

    22,637

    20,028

    Deferred tax liabilities

    150,726

    138,828

    Non-current accrued pension and postretirement benefits

    23,769

    23,783

    Other non-current liabilities

    30,861

    24,445

    Total liabilities

    1,449,914

    1,256,466



    Equity





    Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding

       September 30, 2025 – 17,367,942 shares; December 31, 2024 – 17,673,607 shares

     

    17,368

     

    17,674

    Capital in excess of par value

    876,911

    903,781

    Retained earnings

    584,706

    633,731

    Accumulated other comprehensive loss

    (115,333)

    (201,619)

    Total Quaker shareholders' equity

    1,363,652

    1,353,567

    Noncontrolling interest

    3,231

    616

    Total equity

    1,366,883

    1,354,183

    Total liabilities and equity

    $       2,816,797

    $      2,610,649

     

    Quaker Chemical Corporation

    Condensed Consolidated Statements of Cash Flows

    (Unaudited; Dollars in thousands)





    Nine Months Ended

    September 30,



    2025

    2024

    Cash flows from operating activities





    Net (loss) income

    $          (23,160)

    $          102,540

    Adjustments to reconcile net (loss) income to net cash provided by operating activities:





    Depreciation and amortization

    68,471

    63,159

    Equity in undistributed earnings of associated companies, net of dividends

    (4,366)

    1,045

    Deferred income taxes

    (16,503)

    (7,934)

    Share-based compensation

    10,419

    12,413

    Impairment charges

    88,840

    —

    Restructuring and related charges, net

    31,128

    4,787

    Inventory step-up amortization

    6,022

    —

    Gain on disposal of property, plant, equipment and other assets

    (2,051)

    —

    Other adjustments

    (5,082)

    (4,325)

    Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:





    Accounts receivable

    4,585

    20,625

    Inventories

    (16,473)

    (10,875)

    Prepaid expenses and other current assets

    (4,258)

    (7,912)

    Accrued restructuring

    (21,671)

    (6,397)

    Accounts payable and accrued liabilities

    (25,992)

    (25,612)

     Net cash provided by operating activities

    89,909

    141,514

    Cash flows from investing activities





    Investments in property, plant and equipment

    (33,630)

    (19,337)

    Payments related to acquisitions, net of cash acquired

    (164,209)

    (39,302)

    Proceeds from disposition of assets

    2,992

    2,798

    Other investing activities

    1,828

    —

     Net cash used in investing activities

    (193,019)

    (55,841)

    Cash flows from financing activities





    Payments of long-term debt

    (25,967)

    (48,600)

    Borrowings on revolving credit facilities, net

    168,938

    30,500

    Payments on other debt, net

    (525)

    (842)

    Dividends paid

    (25,583)

    (24,523)

    Shares purchased under share repurchase programs

    (36,496)

    (22,906)

    Other stock related activity

    (1,099)

    (631)

     Net cash provided by (used in) financing activities

    79,268

    (67,002)

     Effect of foreign exchange rate changes on cash

    7,000

    (1,124)

    Net (decrease) increase in cash and cash equivalents

    (16,842)

    17,547

    Cash and cash equivalents at the beginning of the period

    188,880

    194,527

    Cash and cash equivalents at the end of the period

    $          172,038

    $          212,074

     

    Quaker Houghton (PRNewsfoto/Quaker Houghton)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-third-quarter-2025-results-302600230.html

    SOURCE Quaker Chemical Corporation

    Get the next $KWR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KWR

    DatePrice TargetRatingAnalyst
    6/9/2025$146.00Hold → Buy
    Jefferies
    1/7/2025$200.00 → $170.00Overweight → Neutral
    Piper Sandler
    5/16/2024$220.00Overweight
    Piper Sandler
    6/2/2023$250.00Buy
    Stifel
    10/25/2022$196.00Outperform
    RBC Capital Mkts
    1/18/2022$265.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $KWR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2025 RESULTS

    Q3'25 net sales of $493.8 million, an increase of 7% Y/YOrganic sales volumes increased 3% Y/Y driven by new business wins of approximately 5%Q3'25 net income of $30.5 million and earnings per diluted share of $1.75Non-GAAP net income of $36.3 million and non-GAAP earnings per diluted share of $2.08, an increase of 10% Y/YDelivered adjusted EBITDA of $82.9 million, a 5% increase Y/Y, and adjusted EBITDA margins of 16.8%Generated $51.4 million of operating cash flow in Q3'25; Reduced net leverage ratio to 2.4xCONSHOHOCKEN, Pa., Oct. 30, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial process fluids, announced its third quarter 2025 results toda

    10/30/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Third Quarter 2025 Earnings and Investor Call

    CONSHOHOCKEN, Pa., Oct. 16, 2025 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the following schedule and contact information for its third quarter 2025 earnings release and investor call. Earnings Release: Thursday, October 30, 2025 (after market close) Visit the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/  Teleconference: Friday, October 31, 2025, at 8:30 a.m. (ET) Participate live by phone or listen to live audio webcast through the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/  Dial-in Number: +1-877-269-7756 (toll-free) +1-201-689-7817 (toll) Please call 5-10 minutes prio

    10/16/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Leadership Appointments

    CONSHOHOCKEN, Pa., Oct. 1, 2025 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced two executive leadership appointments who will support the execution of our strategic priorities and accelerate the Company's enterprise growth strategy. Christine Johnson has joined the Company as Senior Vice President and Chief Transformation Officer, and Dr. André Frodl, who joined the organization in 2002, has been promoted to Vice President, R&D – Metals and Metalworking.  Joe Berquist, Chief Executive Officer and President stated: "I am thrilled to welcome Christine and congratulate André on his new role. Their leadership will be vital as we advance our strategic priorities and continue deliverin

    10/1/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    SEC Filings

    View All

    SEC Form 10-Q filed by Quaker Houghton

    10-Q - QUAKER CHEMICAL CORP (0000081362) (Filer)

    10/30/25 4:43:10 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - QUAKER CHEMICAL CORP (0000081362) (Filer)

    10/30/25 4:39:05 PM ET
    $KWR
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Quaker Houghton

    10-Q - QUAKER CHEMICAL CORP (0000081362) (Filer)

    7/31/25 4:42:37 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SVP, CTO Johnson Christine Procopio

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    10/17/25 4:19:22 PM ET
    $KWR
    Major Chemicals
    Industrials

    SEC Form 4 filed by VP, R&D-Metals & Metalworking Frodl Andre

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    10/17/25 4:16:25 PM ET
    $KWR
    Major Chemicals
    Industrials

    SEC Form 3 filed by new insider Johnson Christine Procopio

    3 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    10/2/25 4:14:30 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quaker Chemical upgraded by Jefferies with a new price target

    Jefferies upgraded Quaker Chemical from Hold to Buy and set a new price target of $146.00

    6/9/25 7:44:36 AM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Chemical downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Quaker Chemical from Overweight to Neutral and set a new price target of $170.00 from $200.00 previously

    1/7/25 8:12:21 AM ET
    $KWR
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Quaker Chemical with a new price target

    Piper Sandler initiated coverage of Quaker Chemical with a rating of Overweight and set a new price target of $220.00

    5/16/24 7:34:46 AM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Berquist Joseph A bought $49,944 worth of shares (482 units at $103.62), increasing direct ownership by 4% to 12,243 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    5/13/25 4:17:17 PM ET
    $KWR
    Major Chemicals
    Industrials

    Gulf Hungary Holding Korlatolt Felelossegu Tarsasag sold 17,737 shares and bought 17,737 shares, decreasing direct ownership by 78% to 5,017 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/5/23 2:11:28 PM ET
    $KWR
    Major Chemicals
    Industrials

    Qh Hungary Holdings Ltd bought 17,737 shares, increasing direct ownership by 0.44% to 4,010,114 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/5/23 2:08:14 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Financials

    Live finance-specific insights

    View All

    QUAKER HOUGHTON ANNOUNCES THIRD QUARTER 2025 RESULTS

    Q3'25 net sales of $493.8 million, an increase of 7% Y/YOrganic sales volumes increased 3% Y/Y driven by new business wins of approximately 5%Q3'25 net income of $30.5 million and earnings per diluted share of $1.75Non-GAAP net income of $36.3 million and non-GAAP earnings per diluted share of $2.08, an increase of 10% Y/YDelivered adjusted EBITDA of $82.9 million, a 5% increase Y/Y, and adjusted EBITDA margins of 16.8%Generated $51.4 million of operating cash flow in Q3'25; Reduced net leverage ratio to 2.4xCONSHOHOCKEN, Pa., Oct. 30, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial process fluids, announced its third quarter 2025 results toda

    10/30/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Third Quarter 2025 Earnings and Investor Call

    CONSHOHOCKEN, Pa., Oct. 16, 2025 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the following schedule and contact information for its third quarter 2025 earnings release and investor call. Earnings Release: Thursday, October 30, 2025 (after market close) Visit the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/  Teleconference: Friday, October 31, 2025, at 8:30 a.m. (ET) Participate live by phone or listen to live audio webcast through the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/  Dial-in Number: +1-877-269-7756 (toll-free) +1-201-689-7817 (toll) Please call 5-10 minutes prio

    10/16/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2025 RESULTS

    Q2'25 net sales of $483.4 million, an increase of 4% Y/YOrganic sales volumes increased 2% Y/Y driven by new business wins of approximately 5%Q2'25 net loss of $66.6 million and loss per diluted share of $3.78, which includes an $88.8 million impairment chargeQ2'25 non-GAAP net income of $30.0 million and non-GAAP earnings per diluted share of $1.71Delivered adjusted EBITDA and adjusted EBITDA margins of $75.5 million and 15.6%, respectively, in Q2'25Share repurchases totaled $32.7 million in Q2'25 and the Company raised its quarterly cash dividend by approximately 5%CONSHOHOCKEN, Pa., July 31, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial p

    7/31/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Leadership Updates

    Live Leadership Updates

    View All

    Astronics Corporation Appoints Fay West to its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced the appointment of Fay West to its Board of Directors, effective February 6, 2025. Ms. West brings over two decades of financial leadership experience across various industries. Since April 2021, she has served as Senior Vice President and Chief Financial Officer at Tennant Company (NYSE:TNC), a global leader in designing, manufacturing, and marketing solutions that help create a cleaner, safer, and healthier world. Peter J. Gundermann, Chairman, President and CEO, commented, "We are thrilled to welcome Fay to our Board of Director

    2/7/25 8:00:00 AM ET
    $ATRO
    $KWR
    $TNC
    Military/Government/Technical
    Industrials
    Major Chemicals
    Industrial Machinery/Components

    Quaker Houghton Appoints Joseph Berquist as CEO and President

    CONSHOHOCKEN, Pa., Nov. 18, 2024 /PRNewswire/ -- Quaker Houghton ((", the Company", , NYSE:KWR) announced today that its Board of Directors has appointed Joseph Berquist as Chief Executive Officer and President, and a member of the Board of Directors, effective immediately. Mr. Berquist, who succeeds Andy Tometich as Chief Executive Officer and President, most recently served as Executive Vice President and Chief Commercial Officer for Quaker Houghton. Michael F. Barry, Chairman of the Board of Directors of Quaker Houghton commented, "I want to thank Andy for his three years of leadership at Quaker Houghton. His outside perspective and experiences were valuable to help position the Company f

    11/18/24 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Appoints Two New Independent Directors to its Board of Directors

    CONSHOHOCKEN, Pa., July 31, 2024 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the appointment of two new independent directors, Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, to the company's Board of Directors, effective immediately. Michael F. Barry, Chairman of the Board of Directors of Quaker Houghton, stated: "We are extremely pleased to welcome Nandita and Lucrèce to our Board.  They are both skilled global executives with extensive operational and strategic experience across a diverse set of global businesses and industries.  We are confident these proven leaders will make a meaningful contribution to our Board and the Company." Andy Tometich, Chief Executive Officer

    7/31/24 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/17/24 4:18:46 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/12/24 4:59:11 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/9/24 4:07:20 PM ET
    $KWR
    Major Chemicals
    Industrials